Innova Captab Ltd.

•

innovacaptab.comBSE: 544067NSE: INNOVACAP

Market Cap₹ 6,721 Cr.

Current Price

High / Low₹ 1,200 / 622

Stock P/E43.0

Book Value₹ 198

Price to Book3.61

Dividend Yield0.17 %

ROCE15.0 %

ROE13.7 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Drugs & Pharmaceutical Products: 100.0%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 32.5% CAGR over last 5 years
Company has consistently been profitable over the last 5 years
Latest quarter profit grew 42.3% YoY, showing strong momentum
Company has delivered good sales growth of 31.7% CAGR over last 5 years
Company comfortably covers its interest (12.1x coverage)
Company maintains a comfortable, low leverage position

CONS

Equity base is being diluted - shares outstanding up 19.2%
Valuation is stretched - P/E of 43.0 is well above its own 5-year median (27.9)
Though reporting repeated profits, the company pays out little dividend (8.1%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	INNOVACAP	1174.45	43.00	6720.78	0.17	44.13	42.27	470.85	33.94	15.04	15.53

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	233	283	302	263	294	318	316	315	352	380	450	448	471
	202	242	258	225	252	268	270	267	299	329	381	399	414
Operating Profit	31	40	45	38	42	50	47	48	52	52	69	49	57
OPM %	13.42%	14.30%	14.74%	14.50%	14.33%	15.63%	14.71%	15.15%	14.82%	13.63%	15.41%	10.97%	12.10%
	1	3	2	6	2	2	4	3	4	4	2	2	2
Interest	5	9	7	1	0	0	0	2	3	6	4	5	4
Depreciation	3	5	5	3	5	5	5	10	11	11	11	11	12
Profit before Tax	25	30	35	40	39	47	46	39	43	39	56	51	59
Tax %	28.50%	24.12%	28.64%	27.36%	25.01%	25.23%	24.96%	24.78%	27.32%	24.39%	24.30%	20.38%	25.19%
Net Profit	0	0	0	0	29	35	34	30	31	30	42	40	44
	3.67	4.77	4.39	5.02	5.15	6.12	5.97	5.17	5.42	5.18	7.37	7.05	7.71

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	356	373	411	801	926	1,081	1,244	1,630	1,749
	315	322	356	705	813	927	1,058	1,398	1,522
Operating Profit	41	51	54	96	114	154	186	232	227
OPM %	11.46%	13.64%	13.27%	11.99%	12.27%	14.28%	14.97%	14.21%	13.00%
	0	1	1	3	9	12	12	19	9
Interest	6	5	4	6	20	21	2	17	18
Depreciation	11	10	6	8	11	16	25	45	46
Profit before Tax	25	38	46	86	92	130	171	188	205
Tax %	19.74%	25.70%	25.56%	25.39%	25.97%	27.16%	25.00%	25.15%	23.60%
Net Profit	20	28	34	64	68	94	128	141	156
EPS	4.14	5.81	7.19	13.32	14.16	16.49	22.41	24.63	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.12%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 32%
3 Years:: 21%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 33%
3 Years:: 28%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 28%

RETURN ON EQUITY

10 Years:: —
5 Years:: 22%
3 Years:: 15%
Last Year:: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12	12	12	12	48	57	57	57
	70	98	133	197	229	774	902	1,034
	72	54	46	199	245	234	311	315
Trade Payables	62	72	112	145	158	180	202	319
	12	18	102	60	69	85	120	134
Total Liabilities	228	254	404	612	748	1,329	1,592	1,858
	78	73	79	183	183	358	830	842
Capital Work in Progress	0	0	7	0	22	341	23	16
	0	0	0	0	0	0	0	41
	39	65	91	128	117	144	208	283
	0	0	0	0	0	288	332	437
Cash & Bank	2	5	12	2	19	87	68	4
	109	110	215	298	408	111	131	235
Total Assets	228	254	404	612	748	1,329	1,592	1,858

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	28	40	55	80	87	146	64	117
Cash from Investing	-9	-6	-20	-188	-91	-499	-152	-107
Cash from Financing	-9	-23	-19	125	27	361	92	-22
	1	1	3	-5	3	8	4	-12

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	166.01	232.22	286.86	531.54	14.16	16.49	22.41	24.63
Book Value (₹)	687.39	919.62	1206.84	1738.38	57.61	145.20	167.66	190.61
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.00
Cash EPS (₹)	6.36	7.91	8.35	14.89	16.46	19.28	26.74	32.52
PROFITABILITY
Operating Margin %	11.52%	13.96%	13.57%	12.23%	13.07%	14.25%	14.71%	13.96%
Net Margin %	5.58%	7.46%	8.38%	7.91%	7.23%	8.71%	10.13%	8.49%
ROE %	24.10%	28.92%	27.04%	36.19%	28.02%	17.04%	14.33%	13.75%
ROCE %	19.63%	26.48%	28.42%	30.64%	24.34%	19.06%	14.65%	15.04%
	8.72%	11.57%	10.48%	12.58%	9.99%	9.08%	8.78%	8.17%
EFFICIENCY
Debtor Days	93	87	100	79	93	93	89	85
Inventory Days	40	51	70	50	48	44	51	54
Payable Days	101	109	123	89	100	107	109	115
	31	29	47	40	40	31	31	24
FINANCIAL HEALTH
Debt to Equity (x)	0.87x	0.48x	0.31x	0.95x	0.85x	0.29x	0.35x	0.31x
Interest Coverage (x)	5.44x	9.11x	12.80x	16.09x	5.60x	7.04x	72.11x	12.14x
	1.26x	1.39x	1.26x	1.27x	1.59x	2.07x	1.91x	1.83x
GROWTH
Revenue Growth %	0.00%	4.92%	10.00%	94.94%	15.72%	16.72%	15.02%	31.06%
Operating Profit Growth %	0.00%	27.37%	6.94%	77.06%	24.21%	35.90%	18.72%	26.31%
Net Profit Growth %	0.00%	40.30%	23.72%	85.37%	6.26%	38.84%	35.95%	9.87%
	0.00%	0.00%	0.00%	0.00%	0.00%	16.46%	35.95%	9.87%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	27.18x	39.15x	27.91x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	3.09x	5.23x	3.61x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.29%
	0.00x	0.00x	0.00x	0.00x	0.00x	16.29x	26.69x	17.07x

Shareholding Pattern

Numbers in percentages

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	50.90	50.90	50.90	50.90	50.90	50.90	50.90	50.90
	1.01	0.74	0.35	0.23	0.07	0.10	0.23	0.34
	20.61	19.96	19.77	19.67	20.17	20.24	20.14	19.92
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	27.48	28.41	28.99	29.20	28.85	28.76	28.73	28.84

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-05

Copy of Newspaper Publication

2026-09-05 - Innova Captab Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-05

General Updates

2026-09-05 - Innova Captab Limited has informed the Exchange about General Updates

2026-09-04

Shareholders meeting

2026-09-04 - Innova Captab Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

2026-09-03

Copy of Newspaper Publication

2026-09-03 - Innova Captab Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-03

Outcome of Board Meeting

2026-09-03 - Innova Captab Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

2026-08-23

Copy of Newspaper Publication

2026-08-23 - Innova Captab Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-22

General Updates

2026-08-22 - Pursuant to regulation 30 (read with part A of schedule III) and other applicable provisions ofSEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations )and with reference to the our letter dated 24th June, 2026 regarding postponement of22nd Annual General Meeting ( AGM ) of the Company and in continuation of intimation ofoutcome of the Board meeting of the Directors commenced on Friday, 21st August, 2026 at23:16 hours (IST) and concluded on Saturday, 22nd August, 2026 at 00:25 hours (IST), we wish toinform you that the Board of Directors has also approved the notice for calling 22nd AnnualGeneral Meeting ( AGM ) of the Company for the financial year 31st March, 2026. The 22nd AGMNotice along with the annual report will be submitted to the stock exchange(s) in due course oftime.

2026-08-22

Capacity addition

2026-08-22 - Innova Captab Limited has informed the Exchange about Capacity addition

2026-08-22

Outcome of Board Meeting

2026-08-22 - Innova Captab Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

News

Recent coverage and analyst commentary for INNOVACAP

Loading news…

🤖

AI Stock Analyst

Innova Captab Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account